戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tial diameter, respectively, after 15 min of suffusion.
2                                        Prior suffusion of excess L-arginine prevented the increase in
3                                              Suffusion of gingipain RgpA (GRgpA) elicited a significa
4 on were also measured, both before and after suffusion of NMA.
5   EDR impairment was reversed by adventitial suffusion of superoxide dismutase (SOD) of aortas from w
6  intravital microscopy, we found that 20-min suffusion of the extract elicited significant concentrat
7                             In both studies, suffusion of the vessels was performed with filter-steri
8 diameter, n = 41) microvessels following the suffusion of vasoactive drugs was measured with video ca
9                                              Suffusion of venules with this agonist stopped flow prom
10 nitroindazole (7-NI), followed by successive suffusions of the cGMP analogue, 8-bromo-cGMP (8Br-cGMP)
11 esis, addition of 10(-4) M furosemide to the suffusion still caused significant dilation in arteriole
12 pound 48/80, we examined permeability during suffusion with compound 48/80 (25 microg/ml) in the pres
13                                 For example, suffusion with compound 48/80 (25 microg/ml) increased c
14 disruption of the blood-brain barrier during suffusion with compound 48/80, we examined permeability
15 o 76.6% of initial diameter) after 20 min of suffusion with L-NAME, an inhibitor of NO synthesis.
16                                 In contrast, suffusion with SNAP or SIN-1 markedly increased clearanc
17                                We found that suffusion with tiron (1 mM) did not alter basal permeabi
18 uced slowing of flow was reversed rapidly by suffusion with UFH, provided flow had not already stoppe
19                                       During suffusion with vehicle, clearance of FITC-dextran-10K fr
20 ran (M(w)=10000 Da; FITC-dextran-10K) during suffusion with vehicle, S-nitroso-N-acetylpenicillamine
21 amined changes in arteriolar diameter during suffusion with vehicle, SNAP and SIN-1.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。